AI Article Synopsis

  • Breast cancer affects 1 in 8 women, and imaging is crucial for detecting and managing the disease.
  • This review focuses on the latest advancements in PET/CT imaging for breast cancer, including new applications and radiopharmaceuticals for better tumor imaging and therapy.
  • These innovations aim to tailor treatments based on individual tumor profiles and may improve assessment of treatment effectiveness, ultimately enhancing patient outcomes.

Article Abstract

One out of eight women will be affected by breast cancer during her lifetime. Imaging plays a key role in breast cancer detection and management, providing physicians with information about tumor location, heterogeneity, and dissemination. In this review, we describe the latest advances in PET/CT imaging of breast cancer, including novel applications of F-FDG PET/CT and the development and testing of new agents for primary and metastatic breast tumor imaging and therapy. Ultimately, these radiopharmaceuticals may guide personalized approaches to optimize treatment based on the patient's specific tumor profile, and may become a new standard of care. In addition, they may enhance the assessment of treatment efficacy and lead to improved outcomes for patients with a breast cancer diagnosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342839PMC
http://dx.doi.org/10.3390/jcm12134537DOI Listing

Publication Analysis

Top Keywords

breast cancer
20
advances pet/ct
8
pet/ct imaging
8
imaging breast
8
breast
6
cancer
5
imaging
4
cancer women
4
women will
4
will breast
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!